Resistance and tolerance mechanisms play role in cancer as well as infections

In addition to demonstrating that cancer kills flies in dose dependent manner, just as bacteria and viruses cause infections in dose dependent manner, scientists established a system for disentangling resistance and tolerance mechanisms to cancer in a Drosophila model.

A Stanford University lab whose studies have advanced scientific understanding of and tolerance defense mechanisms to bacterial and viral pathogens has now turned its sights on cancer.

"Just as there are resistance and tolerance mechanisms that target invading microbes, we predicted that there are also resistance and tolerance mechanisms that control a host's response to cancer," David Schneider, Ph.D., who heads the lab, and postdoctoral researcher Adler R. Dillman, Ph.D., wrote in their GSA Drosophila Research Conference abstract.

While resistance refers to an organism's ability to rid itself of pathogens, tolerance describes the ability to limit disease severity.

To apply the concepts of resistance and disease tolerance to cancer, Drs. Schneinder and Dillman injected adult Drosophila melanogaster flies with varying doses of fly neoplastic cancer cells containing the Ras gene mutation, one of the most common gene mutations in human cancer. The results enabled the scientists to establish the dose response curve of the fly to the mutation.

They screened over 200 different RNA mediated interference (RNAi) lines targeting immune signaling pathways, metabolism and signal transduction. RNAi inhbits gene expression by triggering the destruction of messenger RNA (mRNA). This genetic screen is ongoing.

In addition to demonstrating that cancer kills flies in a dose dependent manner, just as bacteria and viruses cause infections in a dose dependent manner, Drs. Schneider and Dillman established a system for disentangling the resistance and tolerance mechanisms to in the Drosophila model.

More information: Abstract: "Investigating Resistance and Tolerance to Cancer." Adler R. Dillman, David S. Schneider. Microbiology and Immunology, Stanford, Stanford, CA. abstracts.genetics-gsa.org/cgi… il.pl?absno=14531261

Provided by Genetics Society of America

not rated yet
add to favorites email to friend print save as pdf

Related Stories

New strategies for treatment of infectious diseases

Feb 23, 2012

The immune system protects from infections by detecting and eliminating invading pathogens. These two strategies form the basis of conventional clinical approaches in the fight against infectious diseases. ...

Space-raised flies show weakened immunity to fungus

Jan 24, 2014

Venturing into space might be a bold adventure, but it may not be good for your immune system. Now a study by researchers at the University of California, Davis and published Jan. 24 in the journal PLOS ON ...

Recommended for you

Throwing a loop to silence gene expression

11 hours ago

All human cells contain essentially the same DNA sequence – their genetic information. How is it possible that shapes and functions of cells in the different parts of the body are so different? While every cell's DNA contains ...

A nucleotide change could initiate fragile X syndrome

Sep 01, 2014

Researchers reveal how the alteration of a single nucleotide—the basic building block of DNA—could initiate fragile X syndrome, the most common inherited form of intellectual disability. The study appears ...

Gene clues to glaucoma risk

Aug 31, 2014

Scientists on Sunday said they had identified six genetic variants linked to glaucoma, a discovery that should help earlier diagnosis and better treatment for this often-debilitating eye disease.

User comments